The role of biosimilars in value-based oncology care

The role of biosimilars in value-based oncology care

Kashyap B Patel,1 Luiz H Arantes Jr,2 Wing Yu Tang,3 Selwyn Fung4 1Carolina Blood and Cancer Care, Rock Hill, SC, USA; 2Biosimilars Global Medical Affairs, Pfizer Essential Health, Pfizer Inc. New York, NY, USA; 3Health Economics and Outcomes Research, Pfizer Health & Impact, Pfizer Essentia...

Full description

Bibliographic Details
Main Authors: Patel KB, Arantes Jr LH, Tang WY, Fung S
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:Cancer Management and Research
Subjects:
biologics
biosimilars
oncology
patient access
value-based care
supportive care
Online Access:https://www.dovepress.com/the-role-of-biosimilars-in-value-based-oncology-care-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/the-role-of-biosimilars-in-value-based-oncology-care-peer-reviewed-article-CMAR

Similar Items